MAM
N&D Communications bags Repco Homes account
CHENNAI: New media-advertising agency N & D Communications has bagged the Repco Homes account. Repco Homes is a subsidiary of Repco Bank, a 33 year old bank started by repatriates with 33 branches in South India.
The company has been keeping a low profile so far and N&D will initiate it into its maiden media campaign. The account estimated at Rs.1.5 crores. Most of the money will go into creating television commercials which will be supported by radio and print.
An official release informs that Repco is looking to strengthen its base by making the average Indian’s dream of having a home of his own come true. It offers a variety of homes loans – home loans for residential and commercial purposes besides other specific segments like Working Women Scheme , Fifty Plus Scheme, Gurupranaam Scheme for Teachers , Super Loan Scheme for Legal Heirs and so on. The current market with the increase in double income households and greater diposable incomes is ripe for an initiative of this kind states the release.
N&D has devised a strategy that focusses on the USP of Repco Homes – ‘Home Loans in 3 Days’ – probably the fastest home loan available. The initial foray will be through radio spots in regional languages and print in both English dailies as well as the vernacular. The print ads are strongly wedded to the USP and practicality. The Radio spots use a touch of sentiment and creative cracks in daily life situations to convey the message. The campaign is scheduled to be released in mid-August.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
